Publications by authors named "P Kunz"

In-silico prediction of protein biophysical traits is often hindered by the limited availability of experimental data and their heterogeneity. Training on limited data can lead to overfitting and poor generalizability to sequences distant from those in the training set. Additionally, inadequate use of scarce and disparate data can introduce biases during evaluation, leading to unreliable model performances being reported.

View Article and Find Full Text PDF

To investigate incidence, treatment patterns and outcomes of gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) in the United States. The 2019 National Cancer Database was searched for adult GEP-NEN patients. Main outcomes included overall and site-specific incidence, treatment patterns, and overall survival (OS).

View Article and Find Full Text PDF

Background: Sex disparities are known modifiers of health and disease. In neuroendocrine neoplasms (NENs), sex-based differences have been observed in the epidemiology and treatment-related side effects.

Objectives: To examine sex differences in demographics, diagnoses present during hospital admission, comorbidities, and outcomes of hospital course among hospitalized patients with NENs.

View Article and Find Full Text PDF

This study aimed to identify relationships between external and internal load parameters with subjective ratings of perceived exertion (RPE). Consecutively, these relationships shall be used to evaluate different machine learning models and design a deep learning architecture to predict RPE in highly trained/national level soccer players. From a dataset comprising 5402 training sessions and 732 match observations, we gathered data on 174 distinct parameters, encompassing heart rate, GPS, accelerometer data and RPE (Borg's 0-10 scale) of 26 professional male professional soccer players.

View Article and Find Full Text PDF
Article Synopsis
  • Intrathecal drug administration is a promising method for delivering biologics to the central nervous system (CNS), but there is limited knowledge on how well intrathecally applied antibodies are tolerated and their pharmacokinetics.
  • This study involved administering a human monoclonal antibody against Nogo-A to non-human primates, assessing toxicity, pharmacokinetics, and pharmacodynamics with no observed side effects, indicating good tolerability.
  • Findings showed that the antibody was rapidly cleared from the cerebrospinal fluid but accumulated in the serum, effectively targeting Nogo-A in the CNS, which could enhance therapeutic strategies for CNS diseases.
View Article and Find Full Text PDF